Abstract
Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have